amanda

425 POSTS 0 COMMENTS

Migraines that affect vision may increase risk of irregular heartbeat

People who experience migraine with visual aura may have an increased risk of atrial fibrillation, according to a study published in the online issue...

Empowering clinicians to diagnose neurological diseases

Enabling more clinicians to assess cerebral blood flow characteristics and detect neurological diseases such as stroke using robotic ultrasound technology could help to facilitate...

Urs Fischer

Urs Fischer is a clinical researcher with a particular interest in the diagnosis, management, treatment and outcome of patients with acute neurological diseases, especially...

Time is “money”, not just brain

Thrombectomy is a highly effective way to treat ischaemic large vessel occlusion stroke. “Time is brain” remains crucial as the thrombectomy benefit is highly...

First patient enrolled in TIGER pivotal clinical study

The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...

RAPID CTA gets FDA clearance

iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...

Innovation. Outcomes. Focus on Function.

Medtronic has a long-standing commitment to delivering innovative pain stimulation technology and building the evidence that matters today and leads us into the future. This is again...

To By-Pass or Not To By-Pass

In this educational supplement we focus on ischaemic stroke. We look at the results of the ASTER trial and experts weigh in on the...

WHISPER SCS study: therapy optimisation associated with more effective pain relief

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
New data from the WHISPER randomised controlled trial (RCT) have demonstrated that patients who are given the choice to use both sub-perception and paraesthesia-based...

Significant improvement in time-to-treat in acute stroke patients with STEPS-T

Advertorial An interventional neuroradiology team has recorded significant improvement in time-to-treat in acute ischaemic stroke patients treated with mechanical thrombectomy over a five-year period. The...

Two trials validate use of image-based selection for late window stroke...

With the results of the DAWN trial now published in the New England Journal of Medicine and the late time window data from the...

Spectra WaveWriter Spinal Cord Stimulator System receives FDA approval

The Spectra WaveWriter Spinal Cord Stimulator (SCS) System (Boston Scientific) has received FDA approval. It is the first and only system approved by the...

FDA approves Senza II Spinal Cord Stimulation System

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
The US Food and Drug Administration has approved the next-generation Senza II Spinal Cord Stimulation (SCS) System (Nevro) delivering HF10 therapy. According to the company,...

FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
The US Food and Drug Administration (FDA) has approved a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system (Medtronic),...

First patient enrolled in study to assess optimised spinal cord stimulation...

The first patient has been enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable pain who are...

Vercise deep brain stimulation system gains FDA approval

The US Food and Drug Administration (FDA) has approved the Vercise deep brain stimulation (DBS) system (Boston Scientific). DBS is used to treat the symptoms...

RICOH MEG receives FDA 510(k) clearance

Ricoh has announced that the RICOH MEG Measurement System has received 510(k) clearance from the US Food and Drug Administration (FDA). RICOH MEG, Ricoh’s magnetoencephalography system,...

StimRouter Neuromodulation System eligible for increased Medicare reimbursements

  The Centers for Medicare & Medicaid Service (CMS) has approved significantly larger payment rates for the StimRouter Neuromodulation System (Bioness) in the Hospital Outpatient...

CE mark approval for device to assist in rapid ischaemic stroke...

Cerebrotech Medical Systems has received the CE mark for detection of bioimpedance asymmetry associated with stroke. This latest certification for Cerebrotech’s Intracranial Fluids Monitor (ICF)...

Radiofrequency treatment provides pain relief in new study

A study presented at the annual meeting of the Radiological Society of North America (RSNA, 26 November-1 December, Chicago, USA) has found that the...

NeuroNews Issue 27 – US Edition

Highlights: DEFUSE 3 terminated early with high likelihood of benefit in the endovascular group The top ten takeaways from the AHA/ASA statement on brain...

NeuroNews Issue 27

Highlights: DEFUSE 3 terminated early with high likelihood of benefit in the endovascular group The top ten takeaways from the AHA/ASA statement on brain...

NANS responds to California DWC order to discontinue coverage of non-opioid...

The North American Neuromodulation Society (NANS) has issued a response to the California Division of Workers’ Compensation (DWC) order which adopts regulations to update the evidence-based...

Brave Dreams trial finds venous angioplasty “safe, but largely ineffective” for...

Paolo Zamboni, Ferrara, Italy, the proponent of the chronic cerebrospinal venous insufficiency (CCSVI) theory, and his colleagues have reported that the randomised, double-blinded, sham...

Real-life use of EmboTrap shows comparable outcomes to large stroke studies

The real-life use of the EmboTrap device (Neuravi/Cerenovus) has provided “very good outcomes” when compared to that observed in large mechanical thrombectomy trials which...

3D revascularisation device “valuable adjunct” to ADAPT

According to one presentation given at the Society of NeuroInterventional Surgery’s 14th Annual Meeting (SNIS; 24–27 July, Colorado Springs, USA) the 3D revascularisation device...

Virtual reality training may be as effective as regular therapy after...

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study...

Nevro receives CE mark for full-body MRI conditional labelling with the...

Nevro has received the CE mark for full-body magnetic resonance imaging (MRI) conditional labelling on the Senza Spinal Cord Stimulation (SCS) System delivering HF10...

FDA gives HDE approval for Neuroform Atlas to treat wide neck...

The US Food and Drug Administration has approved the Neuroform Atlas Stent System (Stryker) for marketing under a humanitarian device exemption (HDE). The device...

Intellis platform receives CE mark for spinal cord and peripheral nerve...

Medtronic has received CE mark for the Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in...

AFFINITY Phase 2 MS trial begins

Biogen has announced the recent initiation of the Phase 2 clinical trial AFFINITY, designed to evaluate opicinumab—a human monoclonal antibody targeting LINGO-1—as an investigational...

FDA approves pivotal study of Exablate Neuro for treatment of Parkinson’s...

INSIGHTEC has received approval from the US Food and Drug Administration (FDA) to initiate a pivotal study of the Exablate Neuro for treating dyskinesia...

John Muir Health awarded Comprehensive Stroke Certification Accreditation

John Muir Health’s Walnut Creek Medical Center, Walnut Creek, USA, has been awarded Comprehensive Stroke Certification Accreditation by The Joint Commission, which accredits and...

Aleva Neurotherapeutics raises US$13 million in latest financing round

Aleva Neurotherapeutics has raised US$13 million in a Series D financing round. The round was led by Forrestal Capital, a fund with specific experience...

First US patients treated with HyperArc High Definition Radiotherapy

Five patients with brain cancer became the first patients in the USA to be treated using the HyperArc High Definition Radiotherapy (Varian Medical Systems),...

NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...

NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...

Claret Medical closes US$14.5 million in Series C financing to extend...

Claret Medical, developer of the Sentinel cerebral protection system, has closed on a Series C financing of US$14.5 million led by Lightstone Ventures, with participation...

African Americans live shorter lives due to heart disease and stroke

The average lifespan of African Americans is significantly shorter than white Americans, mostly because of heart disease and stroke, which contributed to more than two million years...

FDA clears first 7T magnetic resonance imaging device

The US Food and Drug Administration has cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic...

FDA approves SenTiva device for treatment of epilepsy

LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...

Risk factors on rise among people with stroke

Despite prevention efforts, researchers have found a significant increase over a 10-year period in the percentage of people with stroke who have high blood...

Transcranial electrical stimulation shows promise for treating mild traumatic brain injury

Using a form of low-impulse electrical stimulation to the brain, documented by neuroimaging, researchers at the University of California San Diego School of Medicine,...

European Stroke Organisation urges Europe to end “stroke care lottery”

Stroke experts from across Europe gathered in Brussels under the umbrella of the European Stroke Organisation (ESO) to call on political leaders to recognise...

Closed-loop spinal cord stimulation may represent new paradigm to mitigate tolerance

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
With six-month follow-up indicating that dorsal column activation is regulated to therapeutic levels by closed-loop spinal cord stimulation (SCS) using evoked compound action potentials...

Door-to-puncture in 15 minutes: one centre’s goal

One New York City-based centre is projecting that door-to-puncture times for the endovascular treatment of acute ischaemic stroke patients can be reduced to as...

Laurent Pierot

Laurent Pierot chose a career in medicine in order to have the skills to help people on a global level. Now, as the current...

FDA clears two spine and brain radiosurgery software applications

Brainlab has received FDA clearance for Elements Spine SRS and Elements Cranial SRS, two software applications that aid in the patient-tailored planning of radiosurgery treatments for indications of...

First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry

  The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...

Reduced stroke and mortality with cerebral protection use in TAVI patients

A new study published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions underscores the role of the Sentinel Cerebral Protection System (Claret...

Flexible battery could revolutionise implanted devices

Experts at Queen’s University Belfast, Belfast, UK, have designed a flexible battery that could provide an alternative to the rigid batteries that usually power...

FDA approves Intellis platform for chronic pain

The US Food and Drug Administration has approved the Intellis spinal cord stimulation platform (Medtronic) for the management of certain types of chronic intractable...

Cerus Endovascular provides corporate update, announces first-in-man use of intra-saccular stent

Cerus Endovascular has provided an update on its lead development programmes, including the Contour Neurovascular System as well as the NEQSTENT Intra-Saccular Stent. “The past...

Cerenovus launches in Europe

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual...

Evidence in favour of DRG stimulation builds with real-world data

The real-world data collected in the PREDICT study has added to the evidence in favour of dorsal root ganglion (DRG) stimulation for the management...

“Better, safer and faster” workflow with new Azurion system

According to early users, the features of the Azurion system—a new imaging system recently released by Philips—make for a “better, safer and faster” workflow,...

DEFUSE 3 terminated early with high likelihood of benefit in the...

Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...

Jason Hannon to replace Peter Crosby as Mainstay chief executive officer

Jason Hannon has been announced as successor to Peter Crosby as chief executive officer of Mainstay Medical, with effect from October 9, 2017. According...

The top ten takeaways from the AHA/ASA statement on brain AVMs

In August, the American Heart Association/American Stroke Association (AHA/ASA) released an update on brain arteriovenous malformations (AVMs) in the form of a new scientific...

No difference in pain relief between 1kHz and 10kHz spinal cord...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A randomised controlled trial has found excellent pain relief and no clinical difference among spinal cord stimulation frequencies from 1kHz–10kHz. Further, the study showed...

Coiling of <5mm aneurysms safe and efficacious in Target registry sub-analysis

Based on a sub-analysis of the data from the prospective Target aneurysm multicentre registry, the coiling of aneurysms <5mm in size with Target coils...

Significant reduction in hospital workflow times with direct transfer to angiosuite

A new study from Barcelona has shown that in a subgroup of patients, direct transfer and triage in the angiosuite seems feasible, safe, and achieves significant...

MRI conditionality across spinal cord stimulation devices: the myths & science

Global use of spinal cord stimulation for treatment of pain is increasing steadily—it is expected that the global market for spinal cord stimulation devices...

US FDA clears Stimwave’s full-body MRI-ready wireless peripheral nerve stimulator

Stimwave has received US Food and Drug Administration (FDA) 510(k) clearance for the first wireless, micro-technology neuromodulation device that can enable ongoing full-body MRI...

Neuros Medical closes US$20 million venture financing deal

Neuromodulation company, Neuros Medical, has closed a US$20 million Series AA venture capital financing. US Venture Partners led the financing, and was joined by...

American men may be having fewer strokes

The overall rate of stroke in the USA has been declining in recent years. However, this may only be good news for men. Research...

Robotic ankle rehabilitation helps post-stroke recovery

A study published in NeuroRehabilitation by Feinstein Institute for Medical Research (Manhasset, USA) scientist Bruce T Volpe and Johanna L Chang has found that...

LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling

LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...

DBS for chronic neuropathic pain efficacious at three years’ follow-up

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A study published in the journal Neuromodulation has shown efficacy at three years’ follow-up for deep brain stimulation (DBS) for the treatment of neuropathic...

Foundational study shows soft suit exoskeleton improves walking for stroke survivors

A new study published in the Journal of Science Translational Medicine finds that use of a soft suit exoskeleton system facilitates normal walking ability...

Trial of third generation cerebral protection device to be initiated by...

Plans to initiate clinical trials for a new, advanced version of the TriGuard cerebral embolic protection device (Keystone Heart) have been announced.  According to the...

New method may help predict risk of bleeding after stroke

A new scoring method may help predict who is at high risk of serious bleeding after a stroke, according to a study published in...

Less than half of US stroke patients are prescribed recommended statins

In the USA, less than half of stroke patients discharged from the hospital received a prescription for statins, and the likelihood of a prescription varied...

Quitting statins after stroke may raise risk of another stroke

Stroke patients who stopped taking statin drugs three to six months after a first ischaemic stroke had a higher risk of a having another stroke...

“It’s About Time…!”

In this supplement: Clinical excellence: Use of real-world data to advance stroke care DAWN Trial results demonstrate a 73% reduction in disability in stroke...

FDA clears Stimpod NMS460 non-invasive neuromodulation device

The US Food and Drug Administration (FDA) has cleared the Stimpod NMS460 (Xavant Technology). With the US patent awarded on proprietary hybrid pulsed radio...

VITAL study shows promise for early identification of serious strokes

The results of the VITAL study demonstrate that a non-invasive, visor-like neurological device (VIPS technology from Cerebrotech Medical Systems) can identify those patients with...

Lucid System gets software update

Neural Analytics has released the latest system update for its next generation ultrasound device, the Lucid M1 Transcranial Doppler Ultrasound System. The Lucid System is...

Transcranial magnetic stimulation may improve accuracy of Alzheimer’s disease diagnosis

Transcranial magnetic stimulation (TMS) may help determine whether a person has Alzheimer’s disease or frontotemporal dementia, according to a preliminary study published in Neurology. “Making the...

Brainstorm receives US$16 million grant for Phase 3 clinical trial of...

Brainstorm Cell Therapeutics has been awarded a US$16 million grant from the California Institute for Regenerative Medicine (CIRM) to support the pivotal Phase 3...

First neonatal magnetic resonance imaging device cleared by US FDA

The US Food and Drug Administration (FDA) has cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in...

Penumbra recalls 3D Revascularization device

According to a release issued by the US Food and Drug Administration (FDA) Penumbra has recalled its 3D Revascularization device due to a wire...

Cerenovus introduced at SNIS

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...

Fujifilm’s T-817MA Alzheimer’s drug fails to meet primary study endpoints

Fujifilm’s T-817MA drug has not met its primary study endpoints of cognition or global clinical function in its US Phase II clinical trial conducted...

Massachusetts General Hospital and California Pacific Medical Center to participate in...

BrainStorm Cell Therapeutics has signed definitive agreements with Massachusetts General Hospital (Boston, USA) and California Pacific Medical Center (CPMC, San Francisco, USA) to enrol...

A third of dementia cases could be prevented by targeting risk...

One in three cases of dementia could potentially be prevented if brain health is improved throughout life by targeting nine risk factors, including continuing...

Rapid Medical announces $9M in new funding

Rapid Medical has completed a Series B financing of $9M to advance the commercialisation of the company’s minimally invasive stroke treatment and prevention products, the Tigertriever...

Innovative Cardiovascular Solutions raises US$5 million in Series B financing for...

Innovative Cardiovascular Solutions (ICS) has completed an oversubscribed Series B round of financing totalling US$5 million. The company is currently developing the EMBLOK Embolic Protection...

Joshua A Hirsch

At just 21-years-old, Joshua A Hirsch was the youngest person in modern history to graduate from his medical school. Since then, he has enjoyed...

Regional shortage of neurologists revealed across the USA

According to new data reported at the 2017 Alzheimer's Association International Conference (AAIC 2017, London, UK), multiple regions of the United States have been...

MMA fighters, boxers may have signs of long-term brain injury in...

Boxers and mixed martial arts fighters may have markers of long-term brain injury in their blood, according to a study presented at the American...

XADAGO (safinamide) now available in the USA for Parkinson’s disease patients

XADAGO (safinamide) is now available as an add-on therapy for US patients with Parkinson’s disease currently taking levodopa/carbidopa and experiencing “off” episodes. It is not...

People with multiple sclerosis face delays in accessing treatments that could...

Sanofi and its specialty care global business unit, Sanofi Genzyme, has published a report—The Missing Pieces, showing that the vast majority (74%) of UK...

SafeOp Surgical files for 10th patent, extending capabilities of its EPAD intraoperative...

SafeOp Surgical has filed its tenth patent application for innovations surrounding the monitoring and real-time detection of motor nerve thresholds during surgery. SafeOp developed...

Sensome raises €4.7m to bring the world’s first connected stroke guidewire...

Sensome, formerly Instent, a company developing a micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, Plaiseau, announced that it has completed...

Contour Neurovascular System receives CE mark approval

The Contour Neurovascular System (Cerus Endovascular) has received CE mark approval for the treatment of intracranial aneurysms. Contour is a unique, fine mesh braid...

NeuroNews Issue 26 – US Edition

Highlights: DAWN of a new era: Time to save brain may be longer than we think ASTER trial final data Joseph Broderick: Physiological time is brain Profile: Joshua...

NeuroNews Issue 26

Highlights: DAWN of a new era: Time to save brain may be longer than we think ASTER trial final data Joseph Broderick: Physiological time is brain Profile: Joshua...

Sleep problems may be early sign of Alzheimer’s

Poor sleep may be a sign that people who are otherwise healthy may be more at risk of developing Alzheimer’s disease later in life...

Traumatic brain injury associated with working-age dementia in nationwide study

According to a study encompassing the entire Finnish population, traumatic brain injury (TBI) is associated with an increased risk for dementia in working-age adults....

Treatment at high-volume centres more beneficial for stroke patients despite transfer...

In a study published in the journal Stroke, Lorenzo Rinaldo and colleagues from the Mayo Clinic, Rochester, USA, have reported that transfer of acute...

Marking 50 years of spinal cord stimulation

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the...

Radiofrequency denervation fails to provide clinically important chronic low back pain...

In three randomised trials, treatment of chronic low back pain (CLBP) with radiofrequency denervation resulted in either no improvement or no clinically important improvement...

UK hospital failed to act lawfully when sharing patient data with...

The UK’s Information Commissioner’s Office (ICO) has found that the Royal Free National Health Service (NHS) Foundation Trust (London, UK) did not adhere to...

Teenage weight gain linked to increased stroke risk as an adult

Kids who become overweight during their teenage years may be more likely to develop a stroke decades later than kids who did not become...

New awards launched to advance research in cognitive aging and age-related...

The McKnight Brain Research Foundation and the American Brain Foundation have announced a new scholarship award intended to will advance research in cognitive aging...

Transcranial stimulation and/or physical therapy improves walking speed in Parkinson’s disease

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Non-invasive brain stimulation and physical therapy—alone or in combination—improve some measures of walking ability in patients with Parkinson’s disease, concludes a clinical trial in...

SureTune3 earns CE mark for deep brain stimulation therapy

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
CE mark has been granted to the SureTune3 software (Medtronic) for deep brain stimulation (DBS). SureTune3 provides patient-specific visualisation of lead location and simulated...

Parkinson’s disease patients first to be treated with Leksell Vantage Stereotactic...

The Leksell Vantage Stereotactic system (Elekta) is now in clinical use at three European centres. The first surgeries were performed on a patient with...

Philips receives FDA 510(k) clearance to market multiple new applications on...

Royal Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) to market IntelliSpace Portal 9.0 and a range of innovative...

LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling

  LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling. According...

CMHP issues positive opinion for Merck’s Cladrabine tablets for multiple sclerosis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for approval of Cladribine...

Philips to acquire Electrical Geodesics

Royal Philips has announced an agreement to acquire Electrical Geodesics, Inc (EGI), a US-based medical device company that designs, develops and commercialises a range...

Spinal cord stimulator implant infection rates decreasing

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A multicentre retrospective study has found that infection rates associated with spinal cord stimulator implants are lower than previously reported and that these rates...

MRI selection slows down randomisation but therapy benefit similar to CTP

A subanalysis from the SWIFT PRIME trial has found that time to randomisation was significantly longer in magnetic resonance imaging (MRI)-selected patients in the...

Physiological time is brain

The DAWN trial results, presented at the European Stroke Organisation Conference (ESOC) by Tudor Jovin and Raul Nogueira, dramatically change the landscape for treatment...

Neurostimulation protocol reduces spasticity in spinal cord injury

Spasticity is a common disorder experienced by patients with spinal cord injuries (SCI). Previous studies have shown that excitatory repetitive transcranial magnetic stimulation (rTMS)...

First patients treated in study of Contour system

The first patients have been enrolled and treated in a prospective, single-arm, multicentre study evaluating the Contour Neurovascular System (Cerus Endovascular). Used for the...

First Canadian Renishaw Neuromate stereotactic robot installed

The first Renishaw Neuromate stereotactic robot in Canada has been installed in the London Health Sciences Centre (LHSC) in London. The first Neuromate-assisted neurosurgical...

Cefaly shown to successfully treat both chronic and refractory migraine

Two newly published clinical trial have demonstrated that Cefaly—the first US Food and Drug Administration-approved external trigeminal nerve stimulation device for the prevention of...

Cirrhosis associated with increased risk of stroke

Cirrhosis was associated with increased risk of stroke, especially haemorrhagic, in a study that included a representative sample of more than 1.6 million Medicare...

Horse, rhythm-and-music therapies may boost recovery after stroke

Horseback riding and rhythm-and-music therapies may improve stroke survivors’ perception of recovery, gait, balance, grip strength and cognition years after their stroke, according to...

CE mark for Vercise Gevia deep brain stimulation system

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
CE mark has been granted for the Vercise Gevia deep brain stimulation (DBS) system (Boston Scientific), a rechargeable, magnetic resonance (MR) conditional device indicated...

SureTune3 deep brain stimulation software receives Health Canada licence

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...

Saluda Medical secures US$40 million in series D financing

Saluda Medical, a medical device company developing a platform of closed-loop neuromodulation technologies based on neural response to stimulation, has secured US$40 million in...

First patient enrolled in APPRISE clinical study for optimisation of Parkinson’s...

  Global Kinetics Corporation (GKC) and the Parkinson’s Foundation have announced that the first of over 400 patients has been enrolled in the GKC APPRISE...

ASTER final data confirm no difference between ADAPT and stent retriever...

The final results of the ASTER randomised controlled trial have confirmed that there was no statistically significant difference between ADAPT (a direct aspiration first...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

DAWN of a new era: Time to save brain may be...

The much-anticipated results from the DAWN trial were finally revealed at the European Stroke Organisation Conference (ESOC; 16–18 May, Prague, Czech Republic) strongly indicating...

Portable transcranial Doppler technology assesses stroke with >95% accuracy

Initial results of the EXPEDITE clinical study have shown Neural Analytics’ Transcranial Doppler technology platform , to be more than 95% accurate for the...

Teva Pharmaceutical launches social media campaign for World MS Day

Teva Pharmaceuticals has announced the launch of its ‘Life Moments with MS’ campaign—a disease awareness initiative, highlighting the challenges faced by multiple sclerosis (MS)...

Q30 Innovations’s Q-Collar may help protect American football players’ brain function

A new study of high school American football players suggests that the Q-Collar from Q30 Innovations may help reduce brain injury from sports-related head...

Longeveron begins enrolment of second cohort of trial of stem cell...

Longeveron has announced that their Phase 1 Alzheimer's disease trial will proceed with enrolment at the recommendation of an independent Data Monitoring Committee (DMC)...

Higher levels of biomarker linked to increased stroke risk for women

Women with elevated levels of a protein in their blood may be at a higher risk of ischaemic stroke, according to a study published...

Consumption of diet drinks associated with increased risk of stroke and...

Drinking at least one artificially sweetened beverage daily has been associated with almost three times the risk of developing stroke or dementia compared to those who drank artificially-sweetened...

Higher trial-to-implant ratio found at high-volume SCS centres

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A study carried out by Kelly Ryan Murphy (Duke University Medical Center, Durham, USA) and colleagues has found that centres with high-volume spinal cord...

Good outcomes doubled with primary stroke centre protocol, study shows

A study published online by JAMA Neurology has found that when a specific primary stroke centre protocol was fully executed in the treatment of...

FDA approves drug to treat ALS

The US Food and Drug Administration has approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Radicava is an intravenous infusion given by...

Giancarlo Barolat

Over a 38-year career, Giancarlo Barolat has performed over 8000 neurostimulation procedures and has seen the field develop and change in a number of...

Stanford Health Care recertified as advanced comprehensive stroke centre

Stanford Health Care has been recertified by The Joint Commission as an advanced comprehensive stroke centre, a designation reserved for institutions with specific abilities...

Helistroke service: flying the physician to the stroke patient works

Flying a stroke specialist by helicopter to a nearby stroke patient for emergency care is feasible, saves money and, most importantly, gets critical care...

Mexican-Americans receive less intensive stroke rehabilitation, new study says

A new pilot study reports that Mexican-American stroke survivors are less likely to receive inpatient rehabilitation than non-Hispanic whites. The study is the next...

First Alzheimer’s trial with focused ultrasound begins

Researchers at Sunnybrook Health Sciences Centre in Toronto, Canada have begun the world’s first clinical trial evaluating the feasibility and safety of opening the...

Ralph L Sacco elected president of American Academy of Neurology

The American Academy of Neurology (AAN) has elected Ralph L Sacco (Miller School of Medicine at the University of Miami, Miami, USA) as its...

University of Miami Health System starts trial to test regenerative treatment...

The University of Miami Health System is starting a clinical trial to further evaluate the safety and efficacy of an investigational cell therapy for...

Worse outcomes with general anaesthesia in pooled analysis of stroke patients

Data from the pooled analysis of the HERMES collaboration have shown that stroke patients given endovascular treatment under general anaesthesia experienced worse outcomes than...

Tecfidera (dimethyl fumarate) and Tysabri (natalizumab) data demonstrate improved outcomes with...

Biogen has announced new real-world data that show treatment with its multiple sclerosis (MS) therapies, Tecfidera (dimethyl fumarate) and Tysabri (natalizumab), early in the...

High patient satisfaction levels for spinal cord stimulation over a 7.5-year...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Data from a single centre using a single spinal cord stimulator manufacturer have shown that patients with neuropathic pain treated with spinal cord stimulation...

NeuroNews Issue 25 – US Edition

Highlights: Worse outcomes with general anaesthesia in pooled analysis of stroke patients ASTER randomised controlled trial Neuromodulation section: High patient satisfaction levels for spinal...

NeuroNews Issue 25

Highlights: Worse outcomes with general anaesthesia in pooled analysis of stroke patients ASTER randomised controlled trial Neuromodulation section: High patient satisfaction levels for spinal...

Findings support role of vascular disease in development of Alzheimer’s disease

Among adults who entered a study more than 25 years ago, an increasing number of midlife vascular risk factors, such as obesity, high blood...

American Heart Association’s Get With The Guidelines programme expands to UAE

The American Heart Association/American Stroke Association (AHA/ASA) is launching its acclaimed Get With The Guidelines in the United Arab Emirates (UAE), which is the...

Toshiba Medical and University of California, San Diego collaborate on advanced...

  Researchers at the University of California, San Diego School of Medicine now have access to Toshiba Medical’s most advanced MR technology for cutting edge research...

Study examines stroke hospitalisation rates, risk factors

A new article published by JAMA Neurology examines acute stroke hospitalisation rates in younger adults aged 18 to 64 years by stroke type and...

Neural Analytics raises US$10 million in new funding round

Neural Analytics, a medical device company developing and commercialising technology to measure, diagnose and track brain health, announced today that it has raised US$10...

Codman Neuro acquires Neuravi

Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...

Australian Therapeutic Goods Administration approves Freedom spinal cord stimulation system

The Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for the Freedom Spinal Cord Stimulation (SCS) System (Stimwave). The company launched the product...

Deep brain stimulation decreases tics in young adults with severe Tourette...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Deep brain stimulation therapy reduces the “tics,” or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to...

Man moves paralysed legs using spinal cord stimulation

Mayo Clinic (Rochester, USA) researchers have used electrical stimulation on the spinal cord and intense physical therapy to help a man intentionally move his...

Medtronic announces voluntary worldwide recall of its StrataMR adjustable valves and...

Medtronic has announced that on 22 February, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR adjustable valves...

Prospective study shows good efficacy with high-frequency spinal cord stimulation in...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A study published in the journal Neuromodulation reports good efficacy with high-frequency spinal cord stimulation with notable reductions on the numerical rating scale back...

Regular exercise, not body mass, before stroke may predict disability later

A new study has suggested that it is the amount of regular exercise people get, not the amount of body fat they have, that...

World Federation of Neurology welcomes WHO classification of stroke as neurological...

A new International Statistical Classification of Diseases and Related Health Problems (ICD) is to be implemented for stroke by the Wold Health Organisation (WHO)....

Janssen and Premier to initiate stroke risk management study among AF...

Janssen Pharmaceuticals has collaborated with Premier on the first and largest study of its kind to address an unmet medical need for hospitalised patients...

Insomnia associated with increased risk of heart attack and stroke

Insomnia is associated with increased risk of heart attack and stroke, according to new research published in the European Journal of Preventive Cardiology. “Sleep is...

FDA approves Ocrevus (ocrelizumab) for relapsing and primary progressive forms of...

Genentech has announced that the US Food and Drug Administration (FDA) has approved Ocrevus (ocrelizumab) as the first and only medicine for both relapsing...

New process designed to streamline faster care for EMS triage, transport...

A new process, developed by the American Heart Association/ American Stroke Association, will help streamline the initial emergency care of stroke patients. The new Severity-based...

Better neck coverage with “bulged centre” of Barrel device in wide-necked...

A single-centre study reports that stent-assisted coiling with the Barrel stent (Medtronic) is a feasible, safe, and efficient method for embolisation of intracranial wide-necked...

Low-profile multicolumn paddle lead improves access to spinal canal

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A low-profile multicolumn paddle lead has provided an option for spinal cord stimulation therapy in an area which traditionally is difficult to access with...

Study shows stem cell therapy is safe for stroke patients

A multicentre trial exploring whether a single dose of millions of adult, bone-marrow-derived stem cells can aid stroke recovery indicates it is safe and...

Portable 3D ultrasound will enable fieldside, roadside screening of head injury

The thin, flexible sheath that protects and insulates our optic nerve is also a window into whether we have had a head injury. Now...

FDA approves safinamide to treat Parkinson’s disease

The US Food and Drug Administration (FDA) has approved safinamide (Xadago) tablets as an add-on treatment for patients with Parkinson's disease who are currently...

Alkermes begins phase 3 gastrointestinal tolerability study of ALKS 8700 for...

Alkermes has initiated a new phase 3 study of ALKS 8700, a novel, oral monomethyl fumarate (MMF) prodrug candidate in development for the treatment...

Vitamin E & selenium supplements do not prevent dementia

Antioxidant supplements vitamin E and selenium – taken alone or in combination – did not prevent dementia in asymptomatic older men, according to a...

TAVI Linked with bleeding in the brain and neurological impairment

Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...

Embol-X and CardioGard do not reduce number of brain lesions, but...

Two US Food and Drug Administration-cleared medical devices designed to remove potential vessel-blocking debris particles from the bloodstream during aortic valve replacement—EmbolX (Edwards LifeSciences)...

ACC 2017: Anticoagulant treatment may be unnecessary for stroke prevention following...

For patients with persistent atrial fibrillation or those who are at high risk for recurring atrial fibrillation, catheter ablation is recommended, followed most often...

First European cases using Emblok cerebral protection take place in Italy

The first European clinical cases using the Emblok Embolic Protection System (Innovative Cardiovascular Solutions) in patients undergoing TAVI (transcatheter aortic valve implantation) procedures have...

CX 2017: Acute Stroke Consensus highlights

Interventions in the aorta and manipulations in the aortic arch have become a “potential source of embolisation to the brain,” notes Roger Greenhalgh, Chairman...

FDA clears Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection

The US Food and Drug Administration (FDA) has given 510(k) clearance to Medtronic for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. A...

ADDRESS trial of Prometra II infusion system begins

The first patients have been implanted with the Prometra II Programmable Infusion System in the ADDRESS (Australian direct drug administration for refractory epilepsy)clinical trial at...

NICE recommends Zinbryta (daclizumab) for relapsing-remitting multiple sclerosis

The National Institute for Health and Care Excellence (NICE) has recommended ZINBRYTA (daclizumab) from Biogen for the treatment of adult patients living with relapsing-remitting...

Patent issued to Perflow Medical for Stream Thrombectomy Net

Perflow Medical has announced the issuance of US Patent No. 9510855, by the US Patent and Trademark Office (USPTO), for the Stream Dynamic Neuro-Thrombectomy...

Enrolment stopped early in DAWN trial

An early end to patient enrolment in the DAWN trial has been activated following a pre-planned interim analysis of the data from the first...

Telemedicine ambulance may deliver faster stroke care

When experiencing a stroke, people who are brought to the hospital in an ambulance with a computed tomography (CT) scanner and telemedicine capabilities are...

Hydrogel coils beat bare platinum in comparison study

The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...

Integra LifeSciences to acquire Codman Neurosurgery business from Johnson & Johnson

Integra LifeSciences Holdings Corporation has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of US$1.045 billion in...

NuvOx Pharma and University of Arkansas begin phase IB/II clinical stroke...

NuvOx Pharma has announced that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed...

Wireless stimulation may ease migraine pain as well as drugs

A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs....

Women may be at higher risk for sports-related concussion than men

Female athletes are 50% more likely than male athletes to have a sports-related concussion, according to a preliminary study released to be presented at the...

Deep brain stimulation treatment for chronic anorexia is safe and may...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a...

Health Canada issues Medical Device License to Elekta for Leksell Gamma...

Health Canada has issued a Medical Device License to Elekta's Leksell Gamma Knife Icon radiosurgery system. Icon is the sixth generation of the Leksell Gamma...

Receiving a clot-buster drug before reaching the hospital may reduce stroke...

Stroke patients receiving clot-busting medications before arriving at the hospital have a lower risk for disability afterward, according to research presented at the American...

Bleeding stroke survivors at higher risk of depression, dementia

People who survive brain bleeds are at significantly higher risk of later developing depression and dementia, according to research presented at the American Stroke...

ESO-ESMINT-ESNR host annual Stroke Winter School

The European Stroke Organisation (ESO), together with the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR), endorsed...

Utility of patient-specific neurovascular models in neurointerventional training

By Andreas MJ Frölich Endovascular aneurysm therapy today is characterised by a rapidly growing and evolving collection of available treatment devices. The challenge in achieving...

ASTER RCT finds no significant difference between ADAPT and stent retriever...

The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique)...

Individualised patient care the future of SCS

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A multicentre, double-blind, randomised and placebo-controlled crossover trial has found that patients with complex regional pain syndrome (CRPS) show preference for different spinal cord...

Enrolment complete in ARISE II trial of EmboTrap device

Enrolment is now complete in the ARISE II clinical trial which is assessing the safety and effectiveness of the EmboTrap II revascularisation device (Neuravi),...

Long-term outcomes following stem cell transplant for multiple sclerosis published in...

A new study published online by JAMA Neurology examines the long-term outcomes of patients with aggressive forms of multiple sclerosis who failed to respond...

Hormone therapy may not protect against Alzheimer’s disease

The latest study on hormone therapy and Alzheimer’s disease shows no relationship between taking the drugs and developing the disease years later. Some previous...

First study of diet’s impact on dementia, Alzheimer’s disease, begins

The first study of its kind designed to test the effects of a diet on the decline of cognitive abilities among a large group...

Blood test may help differentiate Parkinson’s from atypical Parkinsonism disorders

A blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson’s disease or...

How do you design unbiased neuromodulation trials?

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
At the annual meeting of the Neuromodulation Society of the UK and Ireland (NSUKI; 3–4 November, Manchester, USA) Alan Batterham (Health & Social Care...

New guidelines released to improve stroke reporting following cardiac procedures

In response to a growing body of evidence of the existence of "covert" brain injury to patients undergoing transcatheter aortic valve implantation (TAVI) and...

New trends in stroke care—How an insertable cardiac monitor improves AF...

By Anil Yallapragada In 2010, it was reported that the world-wide prevalence of individuals living with a stroke was approximately 33 million,1 with 17 million...

“Further improvement” in aspiration technology with ACE68

In 2016, Penumbra announced the launch of the ACE68 reperfusion catheter, part of the Penumbra System at the Society of NeuroInterventional Surgery 13th Annual...

First commercial implantation of Mainstay Medical’s ReActiv8 performed in Germany

The first commercial implantation of Mainstay Medical’s ReActiv8 has taken place in Germany. The implantation was performed by Francis Kilian, orthopaedic and neurosurgeon at the...

NeuroNews Issue 24 – US Edition

Highlights: Wanted: More interventionalists - Urs Fischer Cleveland Telestroke network at year five Profile: Tudor Jovin Neuromodulation section: - More research needed to show potential of neuromodulation therapy -...

NeuroNews Issue 24

Highlights: Wanted: More interventionalists - Urs Fischer Cleveland Telestroke network at year five Profile: Tudor Jovin Neuromodulation section: - More research needed to show potential of neuromodulation therapy -...

Acclino stents feasible in complex bifurcation aneurysms at mid-term follow-up

A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal...

More research needed to show potential of neuromodulation

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
While much has been done in the past decade to advance the field of neuromodulation, some investigators believe only small steps have been made...

Tudor Jovin

As principal investigator for the REVASCAT and DAWN trials and having leadership roles in the SWIFT PRIME and ESCAPE trials, Tudor Jovin (University of...

Spinal cord stimulation reduces or stabilises opioid use among chronic pain...

New research has found spinal cord stimulation therapy can reduce or stabilise the use of opioids in patients battling chronic pain. Researchers examined opioid...

Proclaim DRG Neurostimulation System introduced in Europe

Abbott has announced the European launch of the new Proclaim DRG Neurostimulation System, designed to deliver dorsal root ganglion (DRG) stimulation to patients suffering...

Siemens Healthineers and Biogen to jointly develop new MRI tools for...

Siemens Healthineers and Biogen have announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key...

ACCURATE 12-month data published in Pain

New data published in the January edition of Pain has confirmed the superiority of dorsal root ganglion (DRG) stimulation therapy (from Abbott) over traditional...

Robert Califf to resign as US FDA commissioner

Robert Califf is to step down as US Food and Drug Administration (FDA) commissioner upon the inauguration of Donald Trump as US President on...

Wanted: More interventionalists

As the number of patients eligible for endovascular treatment of acute ischaemic stroke increases, centres across Europe must consider whether there are enough interventionalists...

AAN releases new guideline on how to map brain prior to...

Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure...

First patient enrolled in haemorrhagic stroke RCT

The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...

Nuvectra picks up New Product Innovation Award for SCS device

Based on its recent analysis of the spinal cord stimulation (SCS) market, Frost & Sullivan has recognised Nuvectra with the 2017 North American New...

Three-dimensional blood vessel examination may improve understanding of dementia and stroke

A study published in the Journal of Anatomy has made a breakthrough in the examination of blood vessels in the brain, giving scientists a...

BrainScope launches Ahead 300 device for objective assessment of mild head...

BrainScope has announced the market release of its flagship Ahead 300 product, and will initiate a limited launch to a select group of thought...

Mediterranean Diet may aid brain volume retention

A new study has shown that older people who followed a “Mediterranean diet” retain more brain volume over a three-year period than those who...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

First-in-human trial of Golden Retriever to take place at Karolinska

Amnis Therapeutics has received approval to perform a first-in-human clinical trial with its neuro thrombectomy device, the Golden Retriever. The approval was received from...

New guidance on neuromodulation therapy to be published

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centred...

Medina embolisation device represents “a major step forward” in aneurysm treatment

According to a report of a single centre’s experience using the Medina embolisation device (Medtronic) for the treatment of unruptured aneurysms, the device “represents...

Brain generates replacement cells after stroke

UCLA researchers have shown that the brain can be repaired—and brain function can be recovered—after a stroke in animals. The discovery could have important...

The Japanese Ministry of Health, Labour and Welfare approves Exablate Neuro...

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved InSightec’s Exablate Neuro system for the non-invasive treatment of essential tremor in patients...

Impact Applications partners with UK’s Football Association to improve brain injury...

Impact Applications has agreed a new partnership with the UK’s Football Association (FA) to enhance the brain injury testing procedures for the football governing...

NICE collaborates with US FDA on Payer Communication Taskforce

The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication...

First large, placebo-controlled double-blind stody of rTMS for Alzheimer’s receives funding

Funding for clinical trials of a new treatment for Alzheimer’s disease has been announced by the Weston Brain Institute, Toronto, Canada. Zahra Moussavi, Canada...

CE mark for full body MR conditional labelling for Proclaim Elite...

The Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical) has received CE mark approval for full-body magnetic resonance (MR) conditional labelling. With...

Codman Neuro announces acquisition of Pulsar Vascular Inc

Codman Neuro has announced the acquisition of Pulsar Vascular Inc, a privately-held company with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy...

Endovascular therapy “appears to benefit” patients with large core and large...

Comparing the outcomes on computed tomography (CT) perfusion of patients with large baseline ischaemic cores undergoing endovascular therapy with the outcomes of matched controls...

Nevro files lawsuit for patent infringement against Boston Scientific in the...

Nevro Corp has announced that it has filed a lawsuit for patent infringement against units of Boston Scientific. The lawsuit, filed in the United States...

Introducing the new Solitaire™ Platinum Revascularization Device

The Solitaire™ Platinum Revascularization Device is the next generation into the Solitaire™ family which has an enhanced meaningful visibility that provides feedback during placement,...

CE mark for Quell wearable pain relief device

NeuroMetrix has received CE mark for the Quell wearable pain relief device. This certification in the European Union allows sales and marketing of Quell...

Neuronix submits neuroAD System for FDA clearance

Neuronix has announced positive results from its pivotal, double-blind placebo-controlled, multicentre clinical study, for the assessment of safety and efficacy of the neuroAD Therapy...

Playing in the NFL may be associated with localised brain injury

The resident immune cells of the central nervous system—microglia—are thought to play a role in the brain’s response to injury and other neurodegenerative processes....

US FDA clears Endophys blood pressure monitor

Endophys has received US Food and Drug Administration (FDA) clearance on its new Blood Pressure Monitor (BPM) that allows an interface to a standard patient...

MedyMatch reveals artificial intelligence deep vision intracranial bleed detection technology

MedyMatch Technology has announced that after several years of extensive research and development, it has achieved a major milestone in the availability, for research,...

Neural Analytics introduces Lucid M1 Transcranial Doppler Ultrasound System

Neural Analytics has announced the commercial launch of its Lucid M1 Transcranial Doppler Ultrasound System, a portable brain monitoring system designed to measure cerebral blood flow velocities...

SVIN announces “Stroke: Mission Thrombectomy 2020”

The Society of Vascular and Interventional Neurology (SVIN) has announced the launch of Mission Thrombectomy 2020, an initiative to enhance global efforts to improve...

Philips to unveil suite of advanced MR-based software applications for assessment...

Royal Philips has announced the introduction of a suite of magnetic resonance (MR)-based software applications dedicated to neurology, which will debut at the Radiological...

Spinal cord stimulation leads to “significant improvement” in gait in Parkinson’s...

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
A recent study explores the safety and efficacy of spinal cord stimulation on gait disturbance in advanced Parkinson’s disease. The investigators found that spinal...

High rate of aneurysm occlusion with p64 at mid- and long-term...

Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term...

FDA expands indication of Solitaire device

The US Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire stent retriever device (Medtronic). The FDA now allows the...

Proclaim Elite spinal cord stimulation system earns full-body MRI compatibility labelling

The US Food and Drug Administration (FDA) has approved full-body magnetic resonance (MR) conditional labelling for the Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical)....

MACRA unmasked

Joshua A Hirsch seeks to break down the Medicare Access and Chip Reauthorization Act of 2015 (MACRA) which is slated to change the face...

Neuravi secures €15 million to fund expansion

Neuravi has announced €15 million in venture debt financing from IPF Partners, a leading alternative financing provider focused on the healthcare sector. This financing allows...

Southeast Pain Care uses new Axium neurostimulator for chronic pain

Southeast Pain Care is one of the first facilities in North Carolina, USA, to use a new neurostimulation device designed to relieve the sensation...

Neighbourhoods important factor in risk of stroke for all races

A higher neighbourhood advantage, or socioeconomic status, of where a person lives contributes to a lower risk of having a stroke no matter the...

FDA clears portable brain monitoring information system

The US Food and Drug Administration has granted 510(k) for the Lucid M1 Transcranial Doppler Ultrasound System. The Lucid System is the first FDA...

New hope for recovery of hand movement for stroke patients

Stroke patients are starting a trial of a new electronic device to recover movement and control of their hand. Neuroscientists at Newcastle University, UK,...

New tool may predict survival after gunshot wounds

Researchers have developed a first-of-its-kind tool to help predict a person’s chance of survival after a gunshot wound in the head or other penetrating...

St Jude Medical shareholders approve merger with Abbott

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October, St...

ANSWER study for wide-neck aneurysms meets primary endpoints

In the ANSWER (Adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction) study of the PulseRider device (Pulsar Vascular), enrolment, 30-day and 180-day follow-up...

NeuroNews Issue 23 – US Edition

Highlights: Expelling bottlenecks key to enhancing stroke pathways of care William Mack: Neuroprotection Profile: Tommy Andersson Neuromodulation section ASRA calls for reconsideration of "experimental"...

NeuroNews Issue 23

Highlights: Expelling bottlenecks key to enhancing stroke pathways of care William Mack: Neuroprotection Profile: Tommy Andersson Neuromodulation section ASRA calls for reconsideration of "experimental"...

Medtronic announces voluntary recall of its Pipeline embolization device, Alligator retrieval...

Medtronic has announced that it has notified customers of a voluntary recall of certain lots of its Pipeline embolization device, Alligator retrieval device and...

Stent retrievers more harmful to arterial wall than ADAPT in animal...

A new study comparing acute damage to the arterial wall caused by ADAPT (a direct aspiration first pass technique) or stent retrievers during thrombectomy...

New stent retriever introduces novel clot capture mechanism

Now that mechanical thrombectomy for the treatment of acute ischaemic stroke is on its way to becoming well-established practice, new devices are beginning to...

Increasing need for use of neuroprotective agents

While the proven success and corresponding uptake of mechanical thrombectomy for the treatment of acute ischaemic stroke has undoubtedly changed the face of stroke...

First patient enrolled in EXPEDITE study to evaluate portable diagnostic platform...

The first patient has been enrolled in the EXPEDITE (Evaluate a next generation portable diagnostic platform for determination and immediate triage of emergency large vessel stroke) phase I clinical study...

Infinity deep brain stimulation system approved in the USA

St Jude Medical has announced the United States Food and Drug Administration approval and first implant of the Infinity deep brain stimulation (DBS) system...

FDA approves BurstDR stimulation for patients with chronic pain

The US Food and Drug Administration (FDA) has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) clinically proven to provide superior outcomes for...

Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...

It has been established that deep brain stimulation is clinically superior to medical therapy for treating advanced Parkinson’s disease. Jan B Pietzsch (Department of...

Expelling bottlenecks key to enhancing stroke pathways of care

There is no doubt now that mechanical thrombectomy has been established as the new standard of care for the treatment of emergent large vessel...

Earlier treatment with surgery to remove blood clot associated with less...

In an analysis that included nearly 1,300 patients with large-vessel ischaemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other...

ARTESp study of pREset device shows 62.5% positive clinical outcome after...

The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischaemic stroke. This was recently proven by four randomised controlled...

FDA clears BrainScope’s Ahead 300 device for assessing traumatic brain injury

BrainScope has announced that the United States Food and Drug Administration (FDA) has cleared the company to market the Ahead 300, its most advanced...

Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....

ReActiv8-A sustains performance at one year in clinical trial

Mainstay Medical International has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single arm trial for ReActiv8 in people...

MRI guidance shows promise in delivering stem cell therapies

Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through...

ECTRIMS and EAN join forces to formulate the first European MS...

A late-breaking session at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS; 14–17 September, London, UK) presented the Clinical Guideline on...

Tecfidera (dimethyl fumarate) real-world studies affirm sustained efficacy and demonstrate nine-year...

Biogen has announced new Tecfidera (dimethyl fumarate) data at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)...

Six year Lemtrada data presented at ECTRIMS

Sanofi Genzyme has announced the presentation six-year investigational data from the extension study of Lemtrada (alemtuzumab) in patients with relapsing remitting multiple sclerosis (RRMS)....

Study urges earlier consideration of spinal cord stimulation in chronic pain...

A study recently published in the journal Neuromodulation suggests that earlier consideration of spinal cord stimulation in chronic pain care continuum could have a...

First-in-man study associated with improved neurological function for stroke patients treated...

In a report published online in the Lancet, investigators describe the results of the phase 1, first-in-man study of human neural stem cells in...

Neurointerventional community moves to “Get Ahead of Stroke”

In recent years the neurointerventional field has seen many changes, especially in the area of stroke treatment. It is now becoming increasingly important how...

Women, minorities may be undertreated for stroke

Women and minorities may be less likely to receive treatment for stroke, according to a study published in a recent online issue of Neurology,...

Tommy Andersson

Tommy Andersson speaks to NeuroNews about how his career developed from physical education teacher to one of the world’s leading interventional neuroradiologists. He also...

SCS TechTalk: Innovation Starts Here

In this Boston Scientific Educational Supplement, you will read about the pace of innovation—from delivering the first and only rechargeable spinal cord stimulation (SCS) system powered by intuitive...

US FDA grants IDE approval to Monteris Medical for glioblastoma multiforme...

The US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) to Monteris Medical  to evaluate the NeuroBlate system in patients...

US FDA clears Icometrix’ image quantification software to monitor neurological disorders

Icometrix has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for their image quantification software, Icobrain. Icobrain is designed to quantify...

Rapid Medical reaches 500 successful aneurysm treatments with Comaneci

Rapid Medical has announced that its Comaneci adjustable remodelling mesh has exceeded 500 successfully treated aneurysms worldwide. This milestone comes two years after the...

Neuravi announces European launch of EmboTrap II stent retriever for treatment...

Neuravi has received CE mark approval for newly available enhancements to its EmboTrap stent retriever platform, the EmboTrap II revascularisation device. The company will...

Two year SENZA-RCT results demonstrate sustained superiority of high-frequency 10 therapy...

Two-year SENZA-RCT results have been published in Neurosurgery, according to Nevro.  The SENZA-RCT is a pivotal study that is both the largest prospective randomised...

US FDA broadens treatment indication for Stryker’s Trevo device

The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...

Whole brain radiotherapy offers little benefit to those whose lung cancer...

People with non-small cell lung cancer, whose disease has spread to the brain, could be spared potentially harmful whole brain radiotherapy, according to new...

BALT International acquires Blockade Medical

BALT International has announced that it has acquired Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices...

World’s largest mobile stroke unit begins test run in Memphis, USA

A Wichita State University nursing faculty member, Wendy Dusenbury, has been invited to join an inaugural group of practitioners at the University of Tennessee...

Scientists discover non-invasive technique to monitor migraines

New University of British Columbia (Vancouver, Canada) research has found that amplified electroencephalograms can produce diagnostic results of cortical spreading depression that are comparable...

Interhospital transfer responsible for delays in revascularisation in stroke patients

Data from the STRATIS registry presented at the Society of NeuroInterventional Surgery annual meeting (SNIS; 25–28 July, Boston, USA) show that the transfer of...

Study links cerebrovascular disease to Alzheimer’s

Diseased blood vessels in the brain itself may contribute more significantly to Alzheimer's disease dementia than was previously believed, according to new study results...

Transcranial magnetic stimulation provides benefits for phantom limb pain

A new study, published in The Journal of Pain, has shown that transcranial magnetic stimulation (rTMS) administered to the scalp can stimulate the brain...

Siemens and InSightec sign strategic agreement to develop compatibility between some...

InSightec has signed a strategic agreement with Siemens Healthineers. The strategic collaboration will involve the development of compatibility between Exablate Neuro and Siemens 1.5T...

CE mark granted to Medtronic for SureTune2 deep brain stimulation therapy

Medtronic has received CE mark for SureTune2 software, which is designed to provide patient-specific visualisation to help physicians make decisions on how to program...

General practitioner records indicate long term effects on patients of transient...

New findings from the University of Birmingham (Birmingham, UK) challenge the ‘transient’ nature of mini-strokes and provide insight into the long-term impact of an...

Most patients with chronic trunk or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...

InSightec Exablate coverage expands to 99.8million US individuals

  Coverage for Exablate (InSightec) for pain palliation of bone metastases in cancer patients has expanded for members of a major health insurance provider in...

Boston Scientific acquires Cosman Medical radiofrequency ablation manufacturer

Boston Scientific Corporation has acquired Cosman Medical a privately-held manufacturer of radiofrequency ablation systems. According to a press release, the Cosman Medical team and...

Medina Embolization Device and Pipeline Shield: LINNC Wrap Up Interviews

Find the latest updates from Prof Monika Killer and Dr Saleh Lamin following this year’s LINNC Congress in Paris. We consider our latest technologies,...

Randomised trial of Penumbra 3D revascularisation device meets primary endpoints

The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...

US FDA grants 510(k) clearance to Relievant Medsystems for Intracept

Relievant Medsystems has received US Food and Drug Administration (FDA) 510(k) clearance for the Intracept intraosseous nerve ablation system. According to a company release, the...

Cefaly releases revamped pocket-sized model of migraine headband

Cefaly has announced that its eponymous Cefaly device—which is a US Food and Drug Administration (FDA)-approved external trigeminal nerve stimulation device for the prevention...

Stereotactic radiosurgery can result in less cognitive deterioration in certain patients

Among patients with one to three brain metastases, the use of stereotactic radiosurgery alone, compared with stereotactic radiosurgery combined with whole brain radiotherapy, resulted...

Codman Neuro agrees US distribution of InNeuroCo intermediate catheters

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo for exclusive US and European distribution...

US FDA releases draft guidance on real-world evidence and medical device...

The US Food and Drug Administration (FDA) has released a draft guidance document entitled “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical...

Neuravi appoints Robert Colloton as vice president of US Sales and...

Neuravi has announced that Robert Colloton has joined the company’s senior management team as vice president of US Sales and Marketing. According to a company...

Female smokers face greatest risk for brain bleeds

Subarachnoid haemorrhage is significantly more common among smokers, especially female smokers, than among people who do not smoke, according to new research published in Stroke. Although...

Penumbra launches ACE 68 reperfusion catheter in USA

Penumbra has launched its new ACE 68 reperfusion catheter in the USA.  The catheter is part of the Penumbra System, and was launched at...

Global study finds stroke largely preventable, with hypertension as biggest risk...

Hypertension remains the single most important modifiable risk factor for stroke, and the impact of hypertension and nine other risk factors together account for...

BrainStorm NurOwn safety shown in US study of with amyotrophic lateral...

BrainStorm Cell Therapeutics has announced results from the recently completed US randomised, double-blind, placebo-controlled phase II study of NurOwn in patients with amyotrophic lateral...

Penumbra 3D trial results to be presented at SNIS 2016

Penumbra has announced its schedule of key events at the Society of NeuroInterventional Surgery (SNIS) 13th Annual Meeting (July 25-28 2016, Boston, USA).  These events...

MicroPort NeuroTech hold results summary meeting for Tubridge multicentre trial

MicroPort NeuroTech has recently held its result-summary meeting, discussing the prospective, multicentre, randomised controlled clinical study for the Tubridge revascularisation device in Shanghai, China....

Mentice receives grant to develop simulation-based training system for stroke treatment

Mentice has received a grant from the Swedish government agency for innovation, Vinnova, to develop a simulation-based training system including validated metrics capable of assessing proficiency...

Higher spinal cord stimulation frequency may reduce epileptic seizure

The ability of spinal cord stimulation to affect spike-and-wave discharges has been suggested as a means to mitigate epileptic seizures in recent literature. In...

New aneurysm device acts as both flow disruptor and diverter

The Contour Neurovascular System (Cerus Endovascular) will offer a new option for treating intracranial aneurysms. According to Kyriakos Lobotesis, Principle Clinical Advisor at Cerus,...

Long-term experience confirms ADAPT as effective treatment for stroke

A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...

The double-edged sword of clinical data sharing

By Joshua A Hirsch The Journal of NeuroInterventional Surgery (JNIS) recently featured a point/counterpoint regarding sharing clinical trial data. In fact, the participants were two...

FDA approves first MRI-guided focused ultrasound device to treat essential tremor

The US Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor in patients who have not responded to...

Air pollution shown to be leading risk factor for stroke worldwide

Air pollution—including environmental and household air pollution—has emerged as a leading risk factor for stroke worldwide, associated with about a third of the global...

Inside the NIH StrokeNet

The National Institutes of Health (NIH) StrokeNet, which was initiated in 2013, currently involves 288 hospitals across the United States and is designed to...

Data show significant favourable results for NICO BrainPath approach

Two peer-reviewed studies recently published in Neurosurgery and Operative Neurosurgery have shown statistically significant data in favour of the BrainPath approach (NICO), citing more...

Debate: IV thrombolysis in acute stroke treatment is dead

It has now been universally accepted that mechincal thrombectomy for the treatment of patients with acute ischaemic stroke with large vessel occlusions is the...

World Stroke Organisation and Medtronic to promote stroke awareness

  The World Stroke Organization has announced a global partnership with Medtronic to increase stroke awareness through several initiatives. The two organisations will work together with...

Digital strategies show promise for emergency heart and stroke care

Mobile devices, social media, visual media and crowdsourcing have the potential to improve emergency care for cardiac arrests, heart attacks and strokes, according to...

Blue Cross Blue Shield denies coverage for high-frequency spinal cord stimulation...

Blue Cross Blue Shield has denied coverage for high frequency spinal cord stimulation in at least two states. Outposts of the federation of...

St Jude Medical launches Infinity deep brain stimulation system and directional...

St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe. The system, which received CE mark approval...

BlueWind Medical receives CE mark for first-to-market miniature overactive bladder wireless...

Bluewind Medical  has received CE marking for its OAB-1000 System, the first in the world miniature wireless neurostimulator to treat overactive bladder (OAB). According to...

Studies show promising results for Q-Collar head collision protection device

Two new studies involving high school football and hockey players have indicated wearing a specifically-designed compression collar around the neck may prevent or reduce...

NeuroNews Issue 22 – US Edition

Highlights: – Mechanical thrombectomy treatment: When does the clock run out? – Brain to Brain debate: Is IV t-PA treatment dead? – Profile: Jacques Moret – Neuromodulation section –...

NeuroNews Issue 22

Highlights: - Mechanical thrombectomy treatment: When does the clock run out? - Brain to Brain debate: Is IV t-PA treatment dead? - Profile: Jacques Moret - Neuromodulation section -...

Pulse frequency is “vital parameter” for successful spinal cord stimulation therapy

The importance of pulse frequency as a parameter in neurostimulation is well-known. Data published in Neuromodulation: Technology at the Neural Interface offer an analysis...

There is a “place” for MR imaging in acute stroke

Magnetic resonance (MR) imaging may have advantages over other imaging modalities in later time windows when it comes to selecting patients for endovascular treatment...

Terumo acquires Sequent Medical

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolisation device. The purchase price...

Concussion outcome predicted with diffusion tensor imaging

Using an advanced imaging technique, researchers at Albert Einstein College of Medicine and Montefiore Health System (Montefiore, USA) were able to predict which patients...

Midlife fitness linked to lower stroke risks later in life

The more fit you are in midlife, the less likely you are to have a stroke after age 65, according to new research published...

Windpact launches Crash Cloud helmet technology

Windpact has launched the Crash Cloud system, with the aim of reducing rates of concussion. The Crash Cloud system is made up of three...

New technique captures the activity of an entire brain in a...

Researchers at The Rockefeller University (New York City, USA) have described a new technique that captures a detailed snapshot of global activity in the...

Hansen Medical files 510(k) application to US FDA for Magellan neurological...

Hansen Medical has recently submitted a 510(k) application to the US Food and Drug Administration for a neurological indication for the Magellan Robotic system....

Synchron appoints Martin Dieck as chairman

Synchron, a new USA-based company focused on the development of minimally invasive neuromodulation technologies, has announced the appointment of Martin Dieck as chairman. Currently focused...

Elekta’s Leksell Gamma Knife Icon cleared for use in Japan and...

Elekta’s Leksell Gamma Knife Icon has been cleared for clinical use by both the Japanese Ministry of Health, Labour and Welfare and the Nuclear...

Canadian Cancer Society-funded glioblastoma trial reduces risk of death by one...

New Canadian research presented in Chicago, USA has shown a significant improvement in the survival rate of a group of elderly patients with glioblastoma,...

AbbVie presents safety and efficacy data for ABT-414

AbbVie has announced that safety and preliminary efficacy data from a Phase 1 study of ABT-414—an investigational antibody drug conjugate (ADC) for epidermal growth...

FDA streamlines “compassionate use” application process

The US Food and Drug Administration (FDA) has finalised its efforts to streamline the “compassionate use” process, used by physicians to access investigational drugs...

US Senate introduces legislation to streamline Medicare beneficiary access to breakthrough...

A new bill introduced to the US Senate by Senator Dan Coats seeks to address the gap between the US Food and Drug Administration...

European Union agrees new rules for approving medical devices and in...

The Netherlands presidency of the European Council and representatives of the European Parliament have reached a political agreement on two draft regulations for medical...

Paraesthesia may increase attention to pain, study finds

A study recently published in the journal Neuromodulation has concluded that using spinal cord stimulation devices, paraesthesia are not necessary for pain relief and...

Jacques Moret

As the course director of the Live Interventional Neuroradiology and Neurosurgery Course (LINNC; 23–25 May, Paris, France) Jacques Moret talks about the importance of...

Mechanical thrombectomy treatment: When does the clock run out?

Is there a time after symptom onset at which acute ischaemic stroke patients should no longer be eligible for mechanical thrombectomy? This has become...

ADAPT to the Challenges of Stroke

Acute ischaemic stroke is the second most common cause of death and disability in Europe. The evidence in the recently published or presented randomised...

Researchers identify genes tied to glioblastoma multiforme

Researchers have identified a group of immune system genes that may play a longevity following the development of glioblastoma multiforme. The research has been...

Nuvectra reports first quarter financial results

Nuvectra has announced the company’s financial results for the first quarter of 2016. According to a press release, total revenue in the first quarter of...

Nevro releases 2016 first quarter financial results

Nevro has reported financial results for the three months ending March 31, 2016. This follows the US Food and Drug Administration (FDA) approval for surgical leads for...

Study highlights importance of treating those at high risk of stroke

A new study published in The New England Journal of Medicine has demonstrated both the importance of, and the challenges associated with, treating people who are at...

CE mark granted to Mainstay Medical for ReActiv8

Mainstay Medical International has received CE mark approval for ReActiv8, its proprietary implantable neurostimulation system designed to treat disabling chronic low back pain. According to...

Health Canada approves Insightec’s Exablate Neuro system for the treatment of...

INSIGHTEC has announced that Health Canada has approved its Exablate Neuro system for the treatment of essential tremor. INSIGHTEC’s Exablate Neuro platform is transforming medicine...

Boston Scientific receives US FDA approval for Precision Montage MRI spinal...

  Boston Scientific Corporation has launched the Precision Montage MRI spinal cord stimulator system after receiving approval from the US Food and Drug Administration (FDA)....

WILLIS included in Shanghai’s Drug Reimbursement List

WILLIS Intracranial Stent Graft System, developed by MicroPort NeuroTech (Shanghai) Co, has been officially included in Shanghai’s Drug Reimbursement List. According to Shanghai’s Medical Insurance...

Thousandth patient enrolled in Stryker’s Trevo Retriever Registry

Data from the first 500 patients enrolled in the Trevo Registry were presented at the European Stroke Organisation Conference (ESOC; 10-12 May, Barcelona, Spain)...

Transplanted nerve cells survive a quarter of a century in a...

In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains...

Ten-year analysis investigates the ideal timing of cranioplasty

Winner of the DePuy Synthes Resident Craniofacial Award, Ryan Patrick Morton presented his research, Timing of Cranioplasty: A 10-year Single-center Analysis of 754 Patients,...

Stimwave announces partnership with Kairuku

Stimwave LLC is to partner with medical product distribution company Kairuku. Predicting an increase in demand for the company’s technology, a Stimwave press release notes...

New laser interstitial thermal therapy for brain lesions data presented at...

New data from two separate studies looking at the use of the NeuroBlate system from Monteris for brain lesions were presented at the American...

Neuravi stent retriever platform receives new US patent

The US Patent and Trademark Office (USPTO) has approved a patent providing additional coverage of Neuravi’s therapeutic stent-retriever platform for the endovascular treatment of...

National Stereotactic Radiosurgery (SRS) patient registry gains momentum

 Brainlab has enrolled 11, to date, of the expected 30 hospitals and healthcare systems in the national Stereotactic Radiosurgery (SRS) Patient Registry. Launched in partnership...

Intraventricular transplantation of autologous bone marrow mesenchymal stem cell in haemorrhagic...

Winner of the American Association of Neurological Surgeons (AANS) International Travel Scholarship, Asra Al Fauzi, presented his research, Intraventricular Transplantation of Autologous Bone Marrow...

Daclizumab demonstrates significant sustained improvements versus interferon beta-1A IM

New daclizumabdata have demonstrated positive cognitive outcomes for daclizumab, targeted and reversible mechanism of action (MOA), and safety profile in patients with relapsing-remitting multiple...

Changes in pulsatility and resistance indices of cerebral arteriovenous malformation feeder...

Winner of the Louise Eisenhardt Traveling Scholarship, Sophia F Shakur, presented her research—Changes in Pulsatility and Resistance Indices of Cerebral Arteriovenous Malformation Feeder Arteries...

American Association of Neurological Surgeons names Frederick A Boop president

Frederick A Boop has been named president of the American Association of Neurological Surgeons (AANS). His appointment was announced during the 84th AANS Annual...

Alex B Valadka named as American Association of Neurological Surgeons president...

Alex B Valadka has been named president elect of the American Association of Neurological Surgeons (AANS). His appointment was announced during the 84th AANS...

Abbott to acquire St Jude Medical

Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure...

Medina Embolization Device

Medina™ is designed as an intra-saccular flow diverter, diverting flow away from the aneurysm sac and through the parent artery by forming a mesh scaffold...

Novel combination technique prevents distal embolisation during thrombectomy

In a study evaluating the safety and feasibility of a combination of proximal internal carotid artery occlusion using a balloon catheter and distal aspiration...

Burst stimulation “generally” more effective than tonic

A new study has concluded that burst spinal cord stimulation is “in general” more effective than tonic stimulation in patients already familiar with spinal...

American Academy of Neurology announces research program recipients

The American Academy of Neurology (AAN) has announced the recipients of the 2016 AAN Research Program. This year’s program has awarded nearly US$3 million...

Ergo Trainer offers a lift for rehabilitation patients

Patients in the UK are learning to walk again and are being given new hope and help from a Danish invention making its UK...

Tecfidera data highlights benefit of early treatment in RRMS

Biogen has announced the presentation of new Tecfidera (dimethyl fumarate) research at the 68th annual meeting of the American Academy of Neurology (AAN; 15–21...

10-year Lemtrada follow-up data presented at AAN

Sanofi Genzyme has  announced that a new long-term analysis detailing 10 years of clinical efficacy of Lemtrada (alemtuzumab) in people with relapsing-remitting multiple sclerosis (RRMS)...

FDA approves new surgical leads for Senza SCS System

Nevro has announced that it has received US Food and Drug Administration (FDA) approval for its surgical leads, which are specifically designed for use...

Immune cells help the brain to self-heal after a stroke

After a stroke, there is inflammation in the damaged part of the brain. Until now, the inflammation has been seen as a negative consequence...

Once-a-day epilepsy drug may prevent seizures as well as twice-a-day drug

A new study suggests that an epilepsy drug that can be taken once a day may control seizures as well as a drug that...

Ultrasound headset may be new way to recognise concussion on the...

Mapping blood flow in the brain of athletes using an advanced form of ultrasound may make it easier to more accurately recognise concussions, according...

To give or not to give IV t-PA: That is the...

By Joshua A Hirsch The year 2015 was a remarkable one for long-term proponents of endovascular therapy for strokes resultant from emergent large vessel occlusion...

Cost-utility analysis of mechanical thrombectomy in the United Kingdom

By Kyriakos Lobotesis To date, five randomised controlled trials have demonstrated the clinical benefit of endovascular therapy compared with intravenous (IV) tissue-type plasminogen activator (t-PA)...

Over-the-counter drug may reverse chronic vision damage caused by multiple sclerosis

A common antihistamine used to treat symptoms of allergies and the common cold, called clemastine fumarate, partially reversed damage to the visual system in...

Toshiba partners with UC Irvine for study of cerebral microbleeds in...

As chronic traumatic encephalopathy stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical...

Golden Retriever safe and effective in pre-clinical trials

Amnis Therapeutics has announced successful results in its pre-clinical trials, which tested the safety and efficacy of the Golden Retriever neuro thrombectomy device. The...

Study finds that more than 40% of retired NFL players had...

More than 40% of retired National Football League (NFL) players in a recent study had signs of traumatic brain injury based on sensitive MRI...

Cornell researchers report blood-brain barrier breakthrough

Cornell researchers have discovered a way to penetrate the blood brain barrier that may soon permit delivery of drugs directly into the brain to...

Transcranial direct current stimulation can boost language comprehension, Penn study finds

How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community. Transcranial...

Zika virus may now be tied to another brain disease

The Zika virus may be associated with an autoimmune disorder that attacks the brain’s myelin similar to multiple sclerosis, according to a small study...

First US commercial implants of Axium DRG system announced

St Jude Medical has announced the US launch and first post-approval implants of the St Jude Medical Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation...

Neuros Medical completes interim analysis of pivotal study for post-amputation pain

Neuros Medical has announced that it has successfully completed a planned interim analysis of its pivotal study. The study is designed to evaluate the...

Monteris Medical receives IDE approval from FDA to evaluate NeuroBlate in...

Monteris Medical has announced that the US Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) to evaluate the NeuroBlate System in...

Data support “careful” use of mechanical thrombectomy in non-top tier evidence...

Investigators have found that with strict adherence to top tier evidence criteria, half of ischaemic stroke patients with emergent large vessel occlusion (ELVO) may...

NICE provides positive guidance on gammaCore treatment for the prevention and...

The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention...

NeuroNews Issue 21 – US Edition

Highlights: Quality over quantity: Consensus document outlines training guidelines for ischaemic stroke intervention Madrid Stroke Network Profile: Guido Guglielmi Neuromodulation section Lumina data demonstrate 70% greater low back pain...

NeuroNews Issue 21

Highlights: Quality over quantity: Consensus document outlines training guidelines for ischaemic stroke intervention Madrid Stroke Network Profile: Guido Guglielmi Neuromodulation section Lumina data demonstrate 70% greater low back pain...

Quality over quantity: Consensus document outlines training guidelines for ischaemic stroke...

Twelve international societies have joined together to produce a consensus document to guide physicians seeking to treat acute ischaemic stroke patients with mechanical thrombectomy...

Guido Guglielmi

World-renowned as the inventor of the Guglielmi Detachable Coil (GDC), Guido Guglielmi speaks to NeuroNews about what inspired him to pursue that invention and...

NeuroMetrix to collaborate with Premera Blue Cross to pilot Quell wearable...

Premera Blue Cross is to pilot the Quell wearable pain relief device within NeuroMetrix. Through this collaboration, Premera will provide Quell devices to selected...

Right brain may help prediction of language recovery after stroke

New research has suggested that looking at structures in the right side of the brain may help predict who will better recover from language...

FDA clears Stimwave’s miniature StimQ peripheral nerve stimulator

Stimwave has begun to market the StimQ peripheral nerve stimulator (PNS) system for the relief of severe intractable chronic pain of peripheral origin. The system...

First mobile stroke unit with advanced CT imaging capabilities launched in...

The University of Tennessee College of Medicine in Memphis, USA has introduced the world’s most comprehensive mobile stroke unit, designed to conduct and produce...

Implementing endovascular treatment for acute ischaemic stroke as the standard of...

Recent evidence demonstrating the effectiveness of endovascular treatment with mechanical thrombectomy for acute ischaemic stroke due to proximal large vessel occlusion in the anterior...

Electrical brain stimulation could support stroke recovery

Applying an electric current to the brain can help recovery from stroke, Oxford University researchers have found. Their research is published in Science Translational Medicine. A...

Insightec broadcasts the first live Exablate Neuro brain treatment at ISTU...

At the 16th International Symposium on Therapeutic Ultrasound 2016 (ISTU) in Tel Aviv, Israel, INSIGHTEC hosted a first time live broadcast from the MRI room...

MR WITNESS: Expanding t-PA for unwitnessed stroke?

Colin Derdeyn interviews Lee Schwamm about the results of the MR WITNESS trial, which he presented at the International Stroke Conference 2016 (ISC; 17-19 February)...

ARUBA: To treat or not to treat unruptured brain arteriovenous malformations

Colin Derdeyn, chair of the leadership committee for the International Stroke Conference 2016 (ISC; 17-19 February) interviews Christian Stapf about the results of ARUBA, which...

Tubridge granted Green Channel status for CFDA approval

The Tubridge Vascular Reconstruction Device from MicroPort was granted Green Channel status to fast track for China Food and Drug Administration (CFDA) approval on...

Debate: Paraesthesia-free spinal cord stimulation: The future, or a phase?

Since the emergence of positive data from the SENZA-RCT study pointing to the validity of high-frequency spinal cord stimulation for back and leg pain...

NeuroNews Issue 20 – US Edition

Highlights: -Knowledge, experience and training are the calling cards of the mechanical thrombectomy operator -No true distinction in selection criteria between HF10 and burst stimulation -Celebrating 25...

NeuroNews Issue 20

Highlights: -Knowledge, experience and training are the calling cards of the mechanical thrombectomy operator -No true distinction in selection criteria between HF10 and burst stimulation -Celebrating 25...

St. Jude Medical: Returning innovation to chronic pain treatment

With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...

Siemens’ Unique Imaging Technologies: Tailored to Enhance Your Stroke Workflow

Siemens’ unique technology optimally supports a one-stop-shop workflow. After clinical NIHSS-based pre-selection, the imaging technologies provided by Siemens help to detect rare cases of...

CNS Cerebrovascular Section Annual Meeting

CNS Cerebrovascular Section Annual Meeting Los Angeles, USA Contact details: W: www.cvsection.org

Celebrating 25 years of the Guglielmi Detachable Coil

By Gary Duckwiler On 28 July 2015 at the 12th Annual Meeting of the Society of NeuroInterventional Surgery (SNIS), a special session was held to...

Debate: Conscious sedation: Is it safe?

Endovascular therapy for the treatment of acute ischaemic stroke has now been established as effective, so far so, that many of the relevant societies...

MicroPort introduces Tubridge aneurysm device

The Tubridge Vascular Reconstruction Device from MicroPort NeuroTech recently drew wide attention in World Live Neurovascular Conference in Chicago, USA. In a micro-surgery procedure...

MicroPort introduces Tubridge aneurysm device

The Tubridge Vascular Reconstruction Device from MicroPort NeuroTech recently drew wide attention in World Live Neurovascular Conference in Chicago, USA. In a micro-surgery procedure...